Agentix Corp. (AGTX)
OTC Markets
Key stats Fiscal year 2026
Income statement
- Net income
- -485,636
- Operating income
- -445,187
- R&D expense
- 125,079
Growth and profitability
- Return on assets
- -62,987.81
Balance sheet
- Total assets
- 771
- Total liabilities
- 3,596,282
- Shareholders' equity
- -3,595,511
- Cash and equivalents
- 771
- Current ratio
- 0.00
Cash flow and ratios
- Operating cash flow
- -108,529
Shareholder returns
- Shares outstanding
- 40,066,951
Company information
- Headquarters
- Dana Point, CA
- Exchange
- OTC Markets
- Fiscal year end
- 03-31
- Industry (SEC)
- Biological Products, (no Diagnostic Substances)
Fiscal year end: · Source: SEC EDGAR
Agentix Corp. trades on OTC Markets under the ticker symbol AGTX. This page brings together its price chart, company profile, key financial figures and technical indicators.